Amgen completes acquisition of Horizon Therapeutics
Oct 6 (Reuters) - Amgen AMGN.O said on Friday it had completed the acquisition of Horizon Therapeutics HZNP.O after it received the go-ahead last month from the U.S. Federal Trade Commission. The companies said in September they expected the deal to close early in the fourth quarter. (Reporting by Mariam Sunny in Bengaluru; Editing by Anil D'Silva) ((Mariam.ESunny@thomsonreuters.com;))
Recent news on Horizon Therapeutics
See all newsDeals of the day-Mergers and acquisitions
Amgen completes $27.8 bln Horizon deal (updated)
Amgen completes acquisition of Horizon Therapeutics
Brief: Amgen Completes Acquisition Of Horizon Therapeutics PLC
On October 5, Court Sanctioned The Scheme Of Arrangement Under Chapter 1 Of Part 9 Of The Irish Companies Act 2014